These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7952)

  • 61. Metoprolol--a new cardioselective beta-adrenoceptor blocking agent for treatment of tachyarrhythmias.
    Wasir HS; Mahapatra RK; Bhatia ML; Roy SB; Sannerstedt R
    Br Heart J; 1977 Aug; 39(8):834-8. PubMed ID: 901674
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
    Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study.
    Xiao J; He P; Zou Q; Zhao Y; Xue Z; Deng X; Li S; Guo Q; Tao G; Yang T; Lang Z; He J; Wang X
    J Clin Anesth; 2015 Mar; 27(2):120-8. PubMed ID: 25434501
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Verapamil in the study and treatment of supraventricular tachycardias, with special reference to pre-excitation].
    Krikler DM
    Minerva Med; 1975 May; 66(39):1914-22. PubMed ID: 236526
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antihypertensive effects of tolamolol.
    Vlachakis ND; Mendlowitz M; Krakoff LR
    Clin Pharmacol Ther; 1977 Jan; 21(1):9-15. PubMed ID: 318950
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immediate effects of intravenous verapamil in cardiac arrhythmias.
    Schamroth L; Krikler DM; Garrett C
    Br Med J; 1972 Mar; 1(5801):660-2. PubMed ID: 5015294
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Medical management of tachycardias (author's transl)].
    Petri H; Rudolph W
    Herz; 1979 Aug; 4(4):344-58. PubMed ID: 93075
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of beta blockade with betaxolol on left ventricular systolic function in chronic stable angina pectoris and left ventricular dysfunction.
    Alpert MA; Singh A; Holmes RA; Sanfelippo JF; Flaker GC; Villarreal D; Mukerji V; Morgan RJ
    Am J Cardiol; 1986 Apr; 57(10):721-4. PubMed ID: 2870631
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of metoprolol in suppressing complex ventricular arrhythmias.
    Pratt CM; Yepsen SC; Bloom MG; Taylor AA; Young JB; Quinones MA
    Am J Cardiol; 1983 Jul; 52(1):73-8. PubMed ID: 6858932
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Spectrum of effects of beta receptor blockade in cardiac arrhythmias].
    Lüderitz B
    Z Kardiol; 1986; 75 Suppl 5():41-6. PubMed ID: 2435070
    [TBL] [Abstract][Full Text] [Related]  

  • 73. beta-blockers for atrial fibrillation: must we consider asymptomatic arrhythmias?
    Page RL
    J Am Coll Cardiol; 2000 Jul; 36(1):147-50. PubMed ID: 10898426
    [No Abstract]   [Full Text] [Related]  

  • 74. [Lowering the heart rate in tachycardiac atrial fibrillation by beta receptor blockade].
    Horn HG; Neuss H; Schlepper M; Mitrovic V; Stämmler G
    Med Klin; 1980 Sep; 75(20):721-5. PubMed ID: 6106885
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Beta-adrenergic blockers in the prevention of sudden death.
    Frishman WH; Laifer LI; Furberg CD
    Cardiovasc Clin; 1985; 15(3):249-64. PubMed ID: 2421902
    [No Abstract]   [Full Text] [Related]  

  • 76. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
    Angaran DM; Schultz NJ; Tschida VH
    Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Beta-adrenergic blockade with INPEA in arrhythmia].
    Cárdenas M; Nadal B; Sanz G
    Arch Inst Cardiol Mex; 1971; 41(1):74-85. PubMed ID: 4942627
    [No Abstract]   [Full Text] [Related]  

  • 79. Esmolol and ventilatory function in cardiac patients with COPD.
    Gold MR; Dec GW; Cocca-Spofford D; Thompson BT
    Chest; 1991 Nov; 100(5):1215-8. PubMed ID: 1682112
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A comparison of the efficacy of sotalol and nadolol in the suppression of ventricular ectopic beats.
    Myburgh DP; Smith R; Diamond TH; Faitelson HL; Sommers DK
    S Afr Med J; 1983 Feb; 63(8):263-5. PubMed ID: 6337412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.